Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: A retrospective analysis of a nationwide registry

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Jansa, Pavel ^a   Jarkovsky, Jiri ^b   Al Hiti, Hikmet ^c   Popelova, Jana ^d   Ambroz, David ^a   Zatocil, Tomas ^e   Votavova, Regina ^a   Polacek, Pavel ^a   Maresova, Jana ^a   Aschermann, Michael ^a   Brabec, Petr ^b   Dusek, Ladislav ^b   Linhart, Ales ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^d NA HOMOLCE HOSPITAL   (Czech Republic)

^e UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Czech Republic; Epidemiology; National registry; Pulmonary arterial hypertension; Survival

Indexed keywords

BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; ILOPROST; PROSTACYCLIN; SILDENAFIL; TREPROSTINIL; PROSTACYCLIN DERIVATIVE; VASODILATOR AGENT;

ADULT; AGED; AORTOPULMONARY SEPTAL DEFECT; ARTERIAL TRUNK; ARTICLE; CONGENITAL HEART DISEASE; CONNECTIVE TISSUE DISEASE; CREATININE CLEARANCE; CZECH REPUBLIC; DISEASE ASSOCIATION; DISEASE REGISTRY; EISENMENGER COMPLEX; EPIDEMIOLOGY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INCIDENCE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATENT DUCTUS ARTERIOSUS; PORTAL HYPERTENSION; PREVALENCE; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SURVIVAL RATE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EPIDEMIOLOGICAL DATA; HAZARD RATIO; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; UNIVARIATE ANALYSIS; YOUNG ADULT;

ADULT; AGED; CZECH REPUBLIC; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84899154026     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-45     Document Type: Article

References (21)

1. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G. ESC Committee for Practice Guidelines (CPG): guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the european society of cardiology (ESC) and the european respiratory society (ERS), endorsed by the international society of heart and lung transplantation (ISHLT). Eur Heart J 2009, 30:2493-2537.
2. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013, 62(25 Suppl):D34-D41.
3. McGoon MD, Benza RL, Escribano-Subias P, Jiang X, Miller DP, Peacock AJ, Pepke-Zaba J, Pulido T, Rich S, Rosenkranz S, Suissa S, Humbert M. Pulmonary arterial hypertension epidemiology and registries. J Am Coll Cardiol 2013, 62(25 Suppl):D34-D41.
4. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007, 30:104-109. 10.1183/09031936.00092306, 17360728.
5. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier J-F, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G. Pulmonary arterial hypertension in France. Results from a national registry. Am J Respir Crit Care Med 2006, 173:1023-1030. 10.1164/rccm.200510-1668OC, 16456139.
6. Escribano-Subías P, Blanco I, López-Meseguer M, Lopez-Guarch CJ, Roman A, Morales A, Morales P, Castillo-Palma MJ, Segovia J, Gómez-Sanchez MA, Barberà JA. REHAP investigators: survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J 2012, 40:596-603. 10.1183/09031936.00101211, 22362843.
7. Tueller C, Stricker H, Soccal P, Tamm M, Aubert JD, Maggiorini M, Zwahlen M, Nicod L. Swiss society of pulmonary hypertension: epidemiology of pulmonary hypertension: new data from the swiss registry. Swiss Med Wkly 2008, 138:379-384.
8. Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, Pepke-Zaba J, Sheares KK, Corris PA, Fisher AJ, Gaine S, Coghlan JG, Wort SJ, Gatzoulis MA, Peacock AJ. Changing demographics, epidemiology and survival of incident pulmonary arterial hypertension. Am J Respir Crit Care Med 2012, 186:790-796. 10.1164/rccm.201203-0383OC, 22798320.
9. Hurdman J, Condliffe R, Elliot CA, Davies C, Hill C, Wild JM, Capener D, Sephton P, Hamilton N, Armstrong IJ, Billings C, Lawrie A, Sabroe I, Akil M, O'Toole L, Kiely DG. ASPIRE registry: assessing the spectrum of pulmonary hypertension identified at a REferral centre. Eur Respir J 2012, 39:945-955. 10.1183/09031936.00078411, 21885399.
10. Frost AE, Badesch DB, Barst RJ, Benza RL, Elliott CG, Farber HW, Krichman A, Liou TG, Raskob GE, Wason P, Feldkircher K, Turner M, McGoon MD. The changing picture of patients with pulmonary arterial hypertension in the united states: how REVEAL differs from historic and non-US contemporary registries. Chest 2011, 139:128-137. 10.1378/chest.10-0075, 20558556.
11. Orphanet report series. Rare diseases collection. Prevalence of rare diseases: bibliographic data. [http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf].
12. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, Levy PS, Pietra GG, Reid LM, Reeves JT, Rich S, Vreim CE, Williams GW, Wu M. Survival in patients with primary pulmonary hypertension. Ann Intern Med 1991, 115:343-349. 10.7326/0003-4819-115-5-343, 1863023.
13. Jansa P, Susa Z, Aschermann M. Center for primary pulmonary hypertension - our first experiences. Cor Vasa 2000, 42:516-517.
14. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, european community for steel and coal. Official statement of the european respiratory society. Eur Respir J Suppl 1993, 6(Suppl 16):5-40.
15. Eurostat. [http://epp.eurostat.ec.europa.eu/portal/page/portal/eurostat/home].
16. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000, 56:337-344. 10.1111/j.0006-341X.2000.00337.x, 10877287.
17. Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from REVEAL. Chest 2012, 142:448-456. 10.1378/chest.1388785, 22281797.
18. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jais X, Montani D, Souza R, Simonneau G. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010, 122:156-163. 10.1161/CIRCULATIONAHA.109.911818, 20585011.
19. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD. Predicting survival in pulmonary arterial hypertension. Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 2010, 122:164-172. 10.1161/CIRCULATIONAHA.109.898122, 20585012.
20. Hoeper MM, Huscher D, Ghofrani HA, Delcroix M, Distler O, Schweiger C, Grunig E, Staehler G, Rosenkranz S, Halank M, Held M, Grohé C, Lange TJ, Behr J, Klose H, Wilkens H, Filusch A, Germann M, Ewert R, Seyfarth HJ, Olsson KM, Opitz CF, Gaine SP, Vizza CD, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Pittrow D. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol 2013, 168:871-880. 10.1016/j.ijcard.2012.10.026, 23164592.
21. Zhang R, Dai LZ, Xie WP, Yu ZX, Wu BX, Pan L, Yuan P, Jiang X, He J, Humbert M, Jing ZC. Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era. Chest 2011, 140:301-309. 10.1378/chest.10-2327, 21330386.